celltrion

Celltrion Reports Sales of KRW 524 Billion and Operating Profit of KRW 183 Billion in Q2

by
Celltrion Reports Sales of KRW 524 Billion and Operating Profit of KRW 183 Billion in Q2

Sales of KRW 524 billion, operating profit of KRW 183 billion, operating margin of 34.9% Commencement of new profitable follow-on pipelines Accelerated growth of Remsima SC centered on Europe, expecting U.S. approval within the year… Prospects for profitability expansion Securing new growth engines by strengthening new drug development capabilities such as ADC Celltrion announced on … Read more

Celltrion Reports Strong Q2 Sales and Profit, Expansion of Biosimilar Pipeline

by
Celltrion Reports Strong Q2 Sales and Profit, Expansion of Biosimilar Pipeline

2Q sales of 524 billion won, operating profit of 183 billion… Initiation of new pipeline supply [프레스나인] Celltrion announced on the 14th that it recorded sales of 524 billion won, operating profit of 183 billion won, and operating margin of 34.9% in the second quarter of this year through the disclosure of consolidated management results. … Read more